Showing results (1-10 of 135) with videos related to
Sort By:
Pageof 14
Internal Medicine Journal|August 2, 2001
Cyclooxygenase inhibitors: any reservations?P S Penglis, M J James, L G ClelandThe Medical Journal of Australia|October 6, 2001
COX-2 inhibition and thrombotic tendency: a need for surveillanceL G Cleland, M J James, L K Stamp, et al.Inflammation Research : Official Journal of the European Histamine Research Society ... [Et Al.]|June 21, 2001
Eicosanoid production by human monocytes: does COX-2 contribute to a self-limiting inflammatory response?M J James, P S Penglis, G E Caughey, et al.Journal of Immunology (Baltimore, Md. : 1950)|July 21, 2000
Differential regulation of prostaglandin E2 and thromboxane A2 production in human monocytes: implications for the use of cyclooxygenase inhibitorsP S Penglis, L G Cleland, M Demasi, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 18, 2001
Roles of cyclooxygenase (COX)-1 and COX-2 in prostanoid production by human endothelial cells: selective up-regulation of prostacyclin synthesis by COX-2G E Caughey, L G Cleland, P S Penglis, et al.Seminars in Arthritis and Rheumatism|November 9, 2000
Genetic susceptibility and the link between cat exposure and rheumatoid arthritisP S Penglis, C Bond, I Humphreys, et al.Journal of Medical Ethics|April 15, 2004
Applying a research ethics committee approach to a medical practice controversy: the case of the selective COX-2 inhibitor rofecoxibM J James, L G ClelandSeminars in Arthritis and Rheumatism|November 14, 1997
Dietary n-3 fatty acids and therapy for rheumatoid arthritisM J James, L G ClelandThe American Journal of Clinical Nutrition|January 5, 2000
Dietary polyunsaturated fatty acids and inflammatory mediator productionM J James, R A Gibson, L G ClelandThe Journal of Rheumatology|July 1, 1992
Determinants of synovial fluid lactate concentrationM J James, L G Cleland, A M RofePageof 14